JP2013515742A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515742A5 JP2013515742A5 JP2012546222A JP2012546222A JP2013515742A5 JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5 JP 2012546222 A JP2012546222 A JP 2012546222A JP 2012546222 A JP2012546222 A JP 2012546222A JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- terbinafine
- preparation
- short
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 5
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N Terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 150000001261 hydroxy acids Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 229960002722 terbinafine Drugs 0.000 claims 3
- 239000002888 zwitterionic surfactant Substances 0.000 claims 3
- 208000010195 Onychomycosis Diseases 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 239000002562 thickening agent Substances 0.000 claims 2
- 230000000699 topical Effects 0.000 claims 2
- 229940047648 COCOAMPHODIACETATE Drugs 0.000 claims 1
- 229940047642 Disodium Cocoamphodiacetate Drugs 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 claims 1
- 229960000699 Terbinafine hydrochloride Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 150000004666 short chain fatty acids Chemical class 0.000 claims 1
- 235000021391 short chain fatty acids Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28996209P | 2009-12-23 | 2009-12-23 | |
| US28996709P | 2009-12-23 | 2009-12-23 | |
| US61/289,962 | 2009-12-23 | ||
| US61/289,967 | 2009-12-23 | ||
| PCT/US2010/061940 WO2011079234A2 (en) | 2009-12-23 | 2010-12-22 | Highly permeating terbinafine formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515742A JP2013515742A (ja) | 2013-05-09 |
| JP2013515742A5 true JP2013515742A5 (US20070167479A1-20070719-C00034.png) | 2014-02-13 |
| JP5829217B2 JP5829217B2 (ja) | 2015-12-09 |
Family
ID=43770418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546222A Expired - Fee Related JP5829217B2 (ja) | 2009-12-23 | 2010-12-22 | 高浸透性テルビナフィン製剤 |
Country Status (7)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2672962T3 (pl) * | 2011-02-11 | 2015-08-31 | Moberg Pharma Ab | Nowa kompozycja przeciwgrzybicza |
| JP6339940B2 (ja) | 2011-12-20 | 2018-06-06 | ビョーメ バイオサイエンシズ ピーブイティー．リミテッド | 真菌感染症の治療用の局所用オイル組成物 |
| EP2664327A1 (en) | 2012-05-14 | 2013-11-20 | Almirall S.A. | Topical pharmaceutical compositions comprising terbinafide and urea |
| NL2009669C2 (en) * | 2012-10-19 | 2014-04-23 | Dutch Renewable Energy B V | Enhanced nail penetrating composition. |
| CA2894696A1 (en) | 2012-12-21 | 2014-06-26 | Teikoku Pharma Usa, Inc. | Compositions and methods for transdermal delivery of hormones and other medicinal agents |
| US8697753B1 (en) * | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| EP2952208A1 (en) * | 2014-06-04 | 2015-12-09 | Universidade de Santiago de Compostela | Hydroalcoholic system for nail treatment |
| SG11201703184SA (en) | 2014-10-21 | 2017-05-30 | Hexima Ltd | A method of treatment |
| KR101690765B1 (ko) * | 2015-04-17 | 2016-12-28 | 동아제약 주식회사 | 항진균성 활성물질을 포함하는 경피 제제 |
| GB201511799D0 (en) * | 2015-07-06 | 2015-08-19 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| WO2017031075A1 (en) * | 2015-08-17 | 2017-02-23 | Arno Therapeutics, Inc. | Methods and compositions for enhanced transungual delivery of ar-12 |
| WO2017062761A1 (en) * | 2015-10-07 | 2017-04-13 | Exodos Life Sciences Lp | Topical antifungal compositions |
| GB201605127D0 (en) * | 2016-03-25 | 2016-05-11 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| EP3468544A2 (en) * | 2016-06-13 | 2019-04-17 | Vyome Therapeutics Limited | Synergistic antifungal compositions and methods thereof |
| WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
| SG10202105118WA (en) | 2016-11-28 | 2021-06-29 | Cellix Bio Private Ltd | Compositions and methods for the treatment of fungal infections |
| WO2019214838A1 (en) * | 2018-05-09 | 2019-11-14 | Eviderm Institute Ab | Use of an alcohol-containing composition for improving the skin barrier function |
| WO2019234546A1 (en) * | 2018-06-04 | 2019-12-12 | Zenvision Pharma Llp | Antifungal cuticle oil composition |
| DK3829601T3 (da) | 2018-08-01 | 2024-09-02 | Edix O Sarl | Injicerbare sammensætninger med depotvirkning til anvendelse til behandling af neglesygdomme |
| EP3603650A1 (fr) | 2018-08-01 | 2020-02-05 | Edix O Sarl | Compositions injectables et a duree d'action prolongee pour leur utilisation dans le traitement de maladies de l'ongle et/ou pour accelerer la croissance de l'ongle |
| CN113208937A (zh) * | 2020-01-21 | 2021-08-06 | 中国医学科学院北京协和医院 | 一种角质软化组合物及其制备方法和应用及治疗灰指甲的外用复方及其制备方法和应用 |
| CN113234028B (zh) * | 2021-04-29 | 2022-08-26 | 上海大学 | 一种5-氟尿嘧啶与肌氨酸的共晶体及其制备方法与用途 |
| CN113786382B (zh) * | 2021-11-04 | 2024-05-28 | 浙江得恩德制药股份有限公司 | 一种盐酸特比萘芬凝胶及制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7713618L (sv) | 1977-12-01 | 1979-06-02 | Astra Laekemedel Ab | Lokalanestetisk blandning |
| IT1180295B (it) | 1984-10-08 | 1987-09-23 | Durst Phototechnik Srl | Ingranditore o riproduttore fotografico a colori |
| FR2673537B1 (fr) | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
| PT981330E (pt) | 1997-05-14 | 2002-12-31 | Galen Chemicals Ltd | Composicoes topicas |
| JP2002512187A (ja) * | 1998-04-17 | 2002-04-23 | バーテック ファーマシューティカルズ，インコーポレイティド | 爪真菌病の処置のための局所製剤 |
| US6368618B1 (en) | 1999-07-01 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
| DE10035991A1 (de) * | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
| CN1703206A (zh) * | 2001-09-04 | 2005-11-30 | 泰姆斯多夫药品有限公司 | 治疗指甲生长功能紊乱失调的膏药 |
| US20030091666A1 (en) * | 2001-11-14 | 2003-05-15 | Howard Murad | Methods and compositions for treating dermatological disorders with Morinda citrifolia |
| US7138394B2 (en) | 2002-09-27 | 2006-11-21 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| AU2004266502B2 (en) | 2002-10-25 | 2010-09-23 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
| PL2106805T3 (pl) * | 2003-03-21 | 2011-10-31 | Nexmed Holdings Inc | Przeciwgrzybicza powłoka na paznokcie |
| US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US20060078599A1 (en) | 2004-10-12 | 2006-04-13 | Mathew Ebmeier | Pharmaceutical composition applicable to body tissue |
| CA2500907A1 (en) | 2005-03-15 | 2006-09-15 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| EP1858556A1 (en) | 2005-03-16 | 2007-11-28 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| GB0511499D0 (en) * | 2005-06-06 | 2005-07-13 | Medpharm Ltd | Topical ungual formulations |
| US20070224261A1 (en) | 2006-03-22 | 2007-09-27 | Peter Draper | Eutectic liquid drug formulation |
| EP2457560A1 (en) | 2006-06-14 | 2012-05-30 | Dr Reddy's Laboratories Limited | Topical compositions |
| WO2008121709A1 (en) * | 2007-03-30 | 2008-10-09 | Transport Pharmaceuticals, Inc. | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
| CA2731455A1 (en) | 2008-07-23 | 2010-01-28 | Gregor Cevc | Methods of administering topical antifungal formulations for the treatment of fungal infections |
| WO2011014850A2 (en) * | 2009-07-31 | 2011-02-03 | Nuvo Research Inc. | Topical eutectic-based formulations |
-
2010
- 2010-12-22 AU AU2010336441A patent/AU2010336441B2/en not_active Ceased
- 2010-12-22 EP EP10801340A patent/EP2544659A2/en not_active Withdrawn
- 2010-12-22 JP JP2012546222A patent/JP5829217B2/ja not_active Expired - Fee Related
- 2010-12-22 WO PCT/US2010/061940 patent/WO2011079234A2/en active Application Filing
- 2010-12-22 CN CN2010800643152A patent/CN102770123A/zh active Pending
- 2010-12-22 CA CA2785643A patent/CA2785643A1/en not_active Abandoned
-
2012
- 2012-06-15 US US13/525,108 patent/US9084754B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515742A5 (US20070167479A1-20070719-C00034.png) | ||
| HRP20171512T1 (hr) | Derivati betulina | |
| JP2008533148A5 (US20070167479A1-20070719-C00034.png) | ||
| JP2016508158A5 (US20070167479A1-20070719-C00034.png) | ||
| JP2011140525A5 (US20070167479A1-20070719-C00034.png) | ||
| WO2012085523A3 (en) | Skin sanitizer compositions comprising alcohol based emulsion | |
| WO2011079234A3 (en) | Highly permeating terbinafine formulation for treating onychomycosis | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| JP2013534248A5 (US20070167479A1-20070719-C00034.png) | ||
| SMT201300095B (it) | Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia | |
| JP2011116787A5 (US20070167479A1-20070719-C00034.png) | ||
| CR20120605A (es) | Formulación tópica para un inhibidor de jak | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| CU20130142A7 (es) | Preparación de gadobutrol de alta pureza | |
| WO2010101742A3 (en) | Ampholytic ter-polymers for use in personal care compositions | |
| BR112012019374A2 (pt) | composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo | |
| NZ596228A (en) | Compositions and methods for the treatment of inflammation | |
| NZ592647A (en) | Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester | |
| JP2018537513A5 (US20070167479A1-20070719-C00034.png) | ||
| BR112013000613A2 (pt) | composições secas e dispositivos que contêm tais composições secas | |
| RU2016106829A (ru) | Применение ингибиторов ацетил-СоА карбоксилазы для лечения обыкновенных угрей | |
| CR20140053A (es) | Formulaciones de ácido desoxicólico y sales del mismo | |
| PT2459153E (pt) | Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar | |
| WO2017132178A3 (en) | Salts of 5-aminolevulinic acid and derivatives | |
| AU2015275248B2 (en) | Legumain activated doxorubicin derivative as well as preparation method and application thereof |
